Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.
Clinical trial NCT04719988 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04719988
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-04
- Primary completion
- 2024-11-21
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.